AVITA Medical CFO granted 2,000 RCEL shares

O'Toole David D reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

O'Toole David D reported acquisition or exercise transactions in this Form 4 filing.

AVITA Medical CFO David D. O'Toole received a grant of 2,000 shares of common stock at a reference value of $3.97 per share. This was a compensation-related award, not an open-market purchase, and increased his directly held stake to 152,927 shares, including unvested RSUs.

Insider Trade Summary

Grant/Award: 2,000 shares

Grant/Award 1 txn

Insider O'Toole David D

Role CFO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,000	$3.97	$8K

Holdings After Transaction: Common Stock — 152,927 shares (Direct)

Footnotes (1)

1. F1. Includes unvested RSUs

Key Figures

Shares granted: 2,000 shares Grant value per share: $3.97 per share Holdings after transaction: 152,927 shares +1 more

4 metrics

Shares granted 2,000 shares Equity award to CFO David D. O'Toole

Grant value per share $3.97 per share Reference value for 2,000-share award

Holdings after transaction 152,927 shares Direct holdings after grant, including unvested RSUs

Transactions acquiring shares 1 transaction Grant/award acquisition in this Form 4

Key Terms

Grant, award, or other acquisition, Restricted Stock Units (RSUs), Form 4, Common Stock

4 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Restricted Stock Units (RSUs) financial

"Footnote states: Includes unvested RSUs"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AVITA Medical (RCEL) report for its CFO?

AVITA Medical reported that CFO David D. O'Toole received a grant of 2,000 shares of common stock. The award was recorded at $3.97 per share and represents compensation rather than an open-market purchase, increasing his overall equity position in the company.

Was the AVITA Medical (RCEL) CFO’s Form 4 transaction a stock purchase or a grant?

The Form 4 shows a stock grant, not a market purchase. CFO David D. O'Toole acquired 2,000 shares through a compensation-related award coded as “A,” indicating a grant, award, or other acquisition, at a reference price of $3.97 per share.

How many AVITA Medical (RCEL) shares does the CFO hold after this grant?

Following the 2,000-share grant, CFO David D. O'Toole directly holds 152,927 shares of AVITA Medical common stock. This figure includes unvested restricted stock units, reflecting his total direct equity exposure reported in this Form 4 filing.

What does the $3.97 figure mean in the AVITA Medical (RCEL) CFO’s Form 4?

The $3.97 figure is the per-share value used to record the 2,000-share grant. It represents the price per share for accounting and disclosure of the award, rather than a price actually paid by the CFO in an open-market transaction.

Do the AVITA Medical (RCEL) CFO’s holdings include unvested RSUs?

Yes. A footnote states that the reported holdings include unvested restricted stock units. This means the 152,927-share total for CFO David D. O'Toole comprises both vested common shares and unvested RSUs tied to future vesting conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Toole David D

(Last) (First) (Middle)

28159 AVENUE STANFORD

SUITE 220 - AVITA MEDICAL

(Street)

VALENCIA CALIFORNIA 91355

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AVITA Medical, Inc. [ RCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		A		2,000	A	$3.97	152,927(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes unvested RSUs

	/s/ David O'Toole	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)